| Literature DB >> 36187062 |
Tomasz Wiatr1, Dominik Choragwicki1, Katarzyna Gronostaj1, Anna Czech1, Mikolaj Przydacz1, Marcin Chlosta1, Lukasz Belch1, Przemyslaw Dudek1, Lukasz Curylo1, Michal Zembrzuski1, Magdalena Pisarska-Adamczyk2, Piotr Chlosta1.
Abstract
Introduction: Radical prostatectomy (RP) is the standard surgical treatment for localized prostate cancer (PCa), with excellent oncologic outcomes; however, complications such as post-prostatectomy incontinence could significantly affect quality of life. Aim: To provide data on long-term urinary functional outcomes of bladder neck preservation (BNP) combined with distal urethral length preservation (DULP) in patients treated with videolaparoscopic prostatectomy. Material and methods: In this retrospective study, data were analysed from 619 consecutive patients who underwent laparoscopic radical prostatectomy (LRP) due to localized prostate cancer between November 2014 and December 2018 in a single tertiary care centre in Poland. Of these patients, 227 had BNP and DULP during the procedure. Urinary continence status was assessed in patients at 3, 6, 12, and 18 months after LRP. Cancer resection was assessed by surgical margin status.Entities:
Keywords: bladder neck preservation; laparoscopic radical prostatectomy; prostate cancer; vesicourethral anastomosis
Year: 2022 PMID: 36187062 PMCID: PMC9511914 DOI: 10.5114/wiitm.2022.118162
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.627
Photo 1A, B – Bladder neck preservation using a bipolar grasper
Baseline patient characteristics
| Parameter | Bladder neck preservation with DULP ( | No bladder neck preservation ( | |
|---|---|---|---|
| Age (median [IQR]) | 65 [61–68] | 64 [59–68] | 0.028 |
| Pre-op PSA (median [IQR]) | 8 [6.1–11.3] | 8 [6.12–12.38] | 0.683 |
| BMI (median [IQR]) | 27.44 [24.90–29.41] | 27.68 [25.2–30.2] | 0.589 |
| Charlson Comorbidity Index (median [IQR]) | 3.0 [2.0–4.0] | 3.0 [2.0–3.0] | < 0.076 |
| Age-adjusted Charlson Index (median [IQR]) | 4.0 [3.0–5.0] | 5.0 [4.0–5.0] | < 0.001 |
| UCSF-CAPRA score (median [IQR]) | 3.0 [2.0–4.0] | 3.0 [2.00–4.00] | 0.774 |
| Biopsy Gleason score (%): | 0.125 | ||
| 1 | 122 (53.7) | 227 (57.9) | |
| 2 | 58 (25.5) | 91 (23.2) | |
| 3 | 17 (7.6) | 38 (9.7) | |
| 4 | 18 (7.9) | 23 (5.9) | |
| 5 | 12 (5.3) | 13 (3.3) | |
| ASA score (%): | 0.006 | ||
| 1 | 17 (7.5) | 20 (5.1) | |
| 2 | 204 (89.9) | 306 (78) | |
| 3 | 6 (2.6) | 66 (16.8) | |
| Prostate volume (TRUS) (median [IQR]) | 40 [43–18.2] | 40 [45.5–23.2] | 0.715 |
| Clinical stage (%): | 0.703 | ||
| cT1 | 128 (56.39) | 230 (58.67) | |
| cT2 | 76 (33.48) | 120 (30.61) | |
| cT3 | 20 (8.81) | 37 (9.43) | |
| cT4 | 3 (1.32) | 5 (1.28) | |
| D’Amico (%) | 0.508 | ||
| Low risk | 81 (35.68) | 134 (34.18) | |
| Intermediate risk | 82 (36.12) | 159 (40.56) | |
| High risk | 64 (28.19) | 99 (25.25) |
DULP – distal urethral length preservation, IQR – interquartile range, pre-op PSA – preoperative prostate-specific antigen, BMI – body mass index, ASA – American Society of Anesthesiologists, UCSF-CAPRA score – University of California San Francisco Cancer of the Prostate Risk Assessment, TRUS – transrectal ultrasound. p – Mann-Whitney test for quantitative variables, chi-squared or Fisher’s exact test for qualitative variables.
Statistically significant (p < 0.05).
Intraoperative and preoperative data
| Parameter | Bladder neck preservation with DULP ( | No bladder neck preservation ( | |
|---|---|---|---|
| Prostate weight [g] (median [IQR]) | 44.09 [37–54] | 47 [38.07–61] | 0.027 |
| Anastomosis time (median [IQR]) | 13 [11–15.25] | 17 [13–25] | < 0.001 |
| Access, | 0.571 | ||
| Transperitoneal | 118 (52) | 213 (54.3) | |
| Extraperitoneal | 109 (48) | 179 (45.7) | |
| Suture type, | < 0.001 | ||
| Continuous | 10 (3.6) | 113 (28.8) | |
| Van Velthoven | 20 (8.8) | 120 (30.5) | |
| V-lock | 197 (86.8) | 159 (40.5) | |
| Surgery time (median [IQR]) | 145 [120–180] | 150 [122.5–195] | 0.012 |
| Length of hospital stay [days] (median [IQR]) | 5 [4–6] | 6 [5–7] | < 0.001 |
| Drainage time [days] (median [IQR]) | 3 [2–3] | 3 [3–5] | < 0.001 |
| Catheterization time (median [IQR]) | 15 [12–18] | 18 [15–21] | < 0.001 |
| Blood loss [ml] (median [IQR]) | 200 [100–217.5] | 200 [145–300] | 0.003 |
| Intraoperative anastomotic leak (median [IQR]) | 19 [8.3] | 65 [16.5] | 0.006 |
| Clavien-Dindo complications in 90 days | 41 (18.06) | 82 (20.9) | 0.451 |
| Clavien-Dindo complications (I–II), | 31 (13.6) | 47 (12) | 0.634 |
| Clavien-Dindo complications (III–IV), | 14 (6.17) | 37 (9.44) | 0.202 |
DULP – distal urethral length preservation, IQR – interquartile range. p – Mann-Whitney test for quantitative variables, χ2 or Fisher’s exact test for qualitative variables.
Statistically significant (p < 0.05).
Functional and pathological results
| Parameter | Bladder neck preservation with DULP ( | No bladder neck preservation ( | |
|---|---|---|---|
| Final Gleason score 3 + 3 = 1, 3 + 4 = 2, 4 + 3 = 3, 8 = 4, 9–10 = 5 (%) ISUP: | 0.794 | ||
| 1 | 56 (24.6) | 98 (25) | |
| 2 | 104 (45.8) | 182 (46.4) | |
| 3 | 45 (19.8) | 75 (19.2) | |
| 4 | 12 (5.4) | 24 (6.1) | |
| 5 | 10 (4.4) | 13 (3.3) | |
| Pathological T stage (%): | 0.796 | ||
| pT2 | 106 (46.8) | 170 (43.4) | |
| pT3a | 104 (45.5) | 182 (46.4) | |
| pT3b | 14 (6.3) | 33 (8.4) | |
| pT4 | 3 (1.4) | 7 (1.8) | |
| Return of continence [months], | < 0.001 | ||
| 3 months | 204 (89.8) | 283 (72.2) | < 0.001 |
| 6 months | 216 (95.1) | 316 (80.6) | < 0.001 |
| 12 months | 217 (95.6) | 369 (94.1) | 0.435 |
| 18 months or never | 225 (99.1) | 382 (97.4) | 0.25 |
| Surgical margin status, | 0.578 | ||
| Positive | 65 (28.7) | 119 (30.36) | |
| Negative | 160 (71.3) | 273 (69.64) |
DULP – distal urethral length preservation, ISUP – International Society of Urological Pathology. p – Mann-Whitney test for quantitative variables, χ2 or Fisher’s exact test for qualitative variables.
Statistically significant (p < 0.05).